Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Four-amino acid part makes enzyme sensitive to finasteride.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Genetically modified plants could be an important source of omega-3 fats to meet global needs.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Skin diseases are very common in poor areas, and there's a need for affordable ways to manage and improve skin health.

A tripeptide-copper complex may help hair grow by increasing cell growth and decreasing cell death.